10:21 ET -- Johnson & Johnson is one of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The healthcare giant reported better-than-expected quarterly sales and profit despite headwinds from a stronger U.S. dollar and rising labor costs. J&J shares slip 0.5% to $165.78. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)

(END) Dow Jones Newswires

October 18, 2022 10:36 ET (14:36 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Johnson and Johnson Charts.